Dr. Paul S. Rava, MD, PhD

Dr. Rava practices at Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island.

Dr. Rava's NPI, 1063641504, was assigned on July 6, 2009. Dr. Rava graduated from SUNY Downstate Health Sciences University in 2008. Dr. Rava holds Rhode Island license MD20328.

Dr. Rava's primary practice is Rhode Island Hospital/Hasbro Children's, at 593 Eddy St, Providence, RI 02903 in Providence County. The practice phone is (401) 444-6966.

Dr. Rava's primary practice is Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island. Dr. Rava is also affiliated with The Miriam Hospital. The medical group on file is Brown Health Medical Group. Dmand AI also links Dr. Rava to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rava practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Rava's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Rava is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Rava's licenses on file in 2 states: Rhode Island and Massachusetts.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Rava treats.

CMS data shows 1,738 Medicare services from Dr. Rava across 17 procedure codes in 2024, for 249 Medicare patients. Medicare paid $119,526 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 249 Medicare patients who saw Dr. Rava in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 32% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rava's median patient age at 68, with 41% women.

In 2024, Dr. Rava wrote 154 Medicare Part D claims for 54 patients. 92% of them were for generic drugs. CMS names the drug for 117 of them, across 6 drugs with 11 or more claims each, at $1,392 in total drug cost. In 2023, CMS named 53 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rava for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 30 papers to Dr. Rava, published from 2011 to 2024. 2016 was the busiest year, with 5. The most frequent topics are Radiosurgery, Brain Neoplasms and Lung Neoplasms. Dr. Rava has published most often in Adv Radiat Oncol. Dr. Rava's most frequent co-authors are Thomas J. Fitzgerald, MD, PhD, Jaroslaw T. Hepel, MD and Deus J. Cielo, MD.

Dr. Rava graduated from SUNY Downstate Health Sciences University in 2008.

Dr. Rava is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.